home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410m.zip
/
M94A2302.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
42 lines
Document 2302
DOCN M94A2302
TI Evaluation on a year period of antiretroviral drug bank for HIV/AIDS
patients of public health services in Chile.
DT 9412
AU Bustos P; Child R; Toro L
SO Int Conf AIDS. 1994 Aug 7-12;10(1):335 (abstract no. PC0275). Unique
Identifier : AIDSLINE ICA10/94370273
AB OBJECTIVES: To evaluate the results obtained with the Anti retroviral
drugs Bank, set up by the National Commission of AIDS of Chile with the
physicians treating HIV/AIDS patients. This in order to increase the
quality of life of people living with HIV/AIDS and the collaboration
between health authorities, National Commission of AIDS, and clinicians
involved in AIDS. METHOD: In December 1992 a Protocol of Antiretroviral
Therapy for Adults was set up by physicians that take care of HIV/AIDS
patients and the National Commission of AIDS from the Ministry of
Health. This protocol includes: conditions for treatment (CD4 < 300 x
mm3), conditions for exclusion (before or after the beginning),
laboratory studies (X ray, serologies, PPD skin test), periodic clinical
controls (monthly), interventions (500mg/d in 3-5 sumministration),
changes of treatment (reduction-suspension), chemoprophilaxis, other
aspects such as pregnancy or interaction with other medicines. AZT
distribution was made all over the country through the public health
services. RESULTS: After a year of accomplishment there was an increase
of 88.2% in the number of patients treated with Zidovudine (AZT)
therapy. In the latest '93 we also began supplying ddI and ddC as
substitution treatments. This programme covers the 86% of HIV/AIDS
patients that the Public Health system takes care. TABULAR DATA, SEE
ABSTRACT VOLUME. CONCLUSIONS: Health care workers must work together
with other sectors--including the economical one, in order to increase
efficiency and to obtain the access to expensive treatments providing
HIV/AIDS patients a better quality of medical care and quality of life.
DE Acquired Immunodeficiency Syndrome/*DRUG THERAPY Adult Antiviral
Agents/*THERAPEUTIC USE Didanosine/THERAPEUTIC USE Human HIV
Infections/*DRUG THERAPY *Medical Indigency Patient Care Team *Public
Health Quality of Life Zalcitabine/THERAPEUTIC USE
Zidovudine/THERAPEUTIC USE MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).